IMMUNOHISTOCHEMISTRY, HMB 45

The IHC – HMB-45 (Human Melanoma Black-45) test is an immunohistochemistry-based diagnostic assay used to detect melanocytic cells in tissue samples. HMB-45 is a monoclonal antibody that reacts with antigens found in immature melanosomes, making it an important marker for identifying melanoma and melanocytic tumors.

This test is widely used in pathology to diagnose and classify malignant melanoma, a serious form of skin cancer that develops from pigment-producing melanocytes. HMB-45 is also useful in identifying certain soft tissue tumors such as angiomyolipoma and perivascular epithelioid cell tumors (PEComas).

Benefits of the Test

• Helps diagnose malignant melanoma
• Assists in identifying melanocytic tumors
• Supports differentiation of melanoma from non-melanocytic cancers
• Improves accuracy in skin cancer diagnosis
• Helps guide oncology treatment planning

Why Doctors Recommend This Test

Doctors recommend the IHC HMB-45 test when there is suspicion of melanoma or pigmented tumors. It is commonly used in:

• Evaluation of suspicious skin lesions
• Diagnosis of malignant melanoma
• Differentiation of metastatic melanoma from other cancers
• Soft tissue tumor classification
• Oncology biopsy interpretation

HMB-45 is often used along with other melanoma markers such as S100, Melan-A (MART-1), SOX10, and Ki-67 to improve diagnostic precision.

Preparation Before Test

No special preparation is required from the patient. Important considerations:

• The test is performed on a skin biopsy or surgical tissue sample
• No fasting or medication restrictions are needed
• Clinical history and dermatoscopy findings may assist interpretation

Normal Reporting Time

The typical turnaround time is 3 to 5 working days, depending on tissue processing and laboratory workload.

Who Should Take This Test

• Patients with suspicious pigmented skin lesions
• Individuals with suspected melanoma
• Cases requiring confirmation of melanocytic tumors
• Patients undergoing skin biopsy evaluation
• Oncology patients needing metastatic tumor classification

The IHC HMB-45 test is an essential diagnostic tool in dermatopathology and oncology. It helps pathologists identify melanocytic tumor cells accurately, ensuring early diagnosis and appropriate treatment planning for melanoma and related tumors.